Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Dipna Pharmachem Management Change

Dipna Pharmachem Limited has recommended the appointment of M/s. Jay Pandya & Associates as Secretarial Auditor for FY 2025-26. The Board also approved a postal ballot for member approval via remote e-voting, commencing April 23, 2026.

Key figures
Execution periodFinancial Year 2025–26
Source

BSE filing, BSE: 543594. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Dipna Pharmachem Ltd: key numbers

Share price
₹3.76
Market cap
₹9.88 Cr
Revenue (annual)
₹129.1 Cr
Net profit (annual)
₹2.63 Cr
P/E (TTM)
3.8×Sector 46.1×
Promoter holding
9.13%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Dipna Pharmachem Ltd

All →

Other management change announcements

All →